New developments in contraception.
Keder
L M
LM
College of Medicine, Department of Obstetrics and Gynecology, Ohio State University, Columbus, OH, USA. Keder.1@osu.edu
D000279:Administration, Cutaneous; D000293:Adolescent; D000328:Adult; D003267:Contraception / Q000379:methods* / Q000639:trends*; D003271:Contraceptive Agents, Female / Q000009:adverse effects / Q000627:therapeutic use; D003274:Contraceptive Devices, Female / Q000009:adverse effects; D017135:Desogestrel; D004958:Estradiol / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D005260:Female; D005544:Forecasting; D006801:Humans; D007436:Intrauterine Devices, Medicated / Q000009:adverse effects; D016912:Levonorgestrel / Q000009:adverse effects / Q000627:therapeutic use; D017258:Medroxyprogesterone Acetate / Q000009:adverse effects / Q000627:therapeutic use; D014753:Vinyl Compounds / Q000009:adverse effects / Q000627:therapeutic use
D003271:Contraceptive Agents, Female; C403500:Lunelle; D014753:Vinyl Compounds; C044815:etonogestrel; D004958:Estradiol; D016912:Levonorgestrel; D017135:Desogestrel; D017258:Medroxyprogesterone Acetate